CMS Entry id: 2709 | Channel: Blog landing page | Template: blog/index

Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

Blog

What does the new FDA guidance mean for clinical trials in early Alzheimer’s disease?

The latest FDA draft guidance for clinical trials in early Alzheimer’s disease presents many new opportunities and challenges for drug development. 

WEBINAR: Finding the right patients for clinical trials in early Alzheimer's disease

Dr Kenton Zavitz, Director of Clinical Affairs at Cambridge Cognition, and Dr Robert Smith, Consultant Neuropsychologist, hosted a webinar to discuss clinical trials for early Alzheimer’s disease.

Join them to hear more about overcoming the barriers to expedite the drug development process.

Tuesday 22nd May 2018, 11 a.m. EDT

web-based testing, wearables, voice recognition, virtual clinical trials, transdiagnostic, test-retest, technology, swm, subjective measures, stigma, spatial planning, social cognition, smartphones, set-shifting, schizophrenia research, schizophrenia, rvp, rule learning, research funding, remote testing, regulations, recruitment, real-world assessments, prodromal, pro-cognitive, presenteeism, precision psychiatry, pre-clinical, pharmacovigilance, personalised medicine, patient-centric, patient screening, patient recruitment, parkinson's disease, pal, ots, opinion piece, occupational health, objective measures, novel, normative data, neurotech, neuroscience, near-patient testing, multiple sclerosis, ms, modelling, mental wellbeing, mental health, mci, major depression, machine learning, lifespan, inpatients, ied, high frequency, healthcare, ert, episodic memory, epidemiology, emotion recognition, efficacy, ecological momentary assessments, ebt, ebbinghaus, early alzheimer's disease, drug development, dopamine, digital tools, digital health, depression, dementia, cognitive testing, cognitive science, cognitive safety, cognitive impairment, cognitive function, cognitive dysfunction, cognitive deficits, cognitive biomarkers, cognitive assessment, cognition kit, cognition, cns summit, clinical trials, clinical trial, clinical symptoms, cias, cgt, cantab research grant, cantab for clinical trials, cantab, brain health, biomarkers, awards, automatic speech recognition, attention, alzheimer's disease, affective cognition, absenteeism,